BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jie, Y
Right arrow Articles by Xu, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jie, Y
Right arrow Articles by Xu, L
British Journal of Ophthalmology 2005;89:364-368
© 2005 BMJ Publishing Group Ltd


EXTENDED REPORT

Non-specific tolerance induced by staphylococcal enterotoxin B in treating high risk corneal transplantation in rats

Y Jie1, Z Pan2, Y Chen3, Y Wei4, W Zhang1, Y Wu1, H Peng5, L Xu1

1 Beijing Institute of Ophthalmology, TongRen Eye Center, TongRen Hospital, Capital University of Medical Sciences, China
2 Beijing Institute of Ophthalmology and the Beijing TongRen Eye Bank, TongRen Eye Center, Beijing TongRen Hospital, Capital University of Medical Sciences, China
3 Department of Immunology, General Hospital of PLA, China
4 Centre Laboratory, Beijing TongRen Hospital, Capital University of Medical Sciences, China
5 Academy of Military Medical Sciences, China

Correspondence to:
Correspondence to:
Zhiqiang Pan
Beijing Institute of Ophthalmology and the Beijing TongRen Eye Bank, Beijing TongRen Eye Centre, Beijing TongRen Hospital, Capital University of Medical Sciences, China; panzhq{at}trhos.com

Aims: To explore the role of staphylococcal enterotoxin B (SEB) in treating high risk corneal keratoplasty in rats.

Methods: Rat corneal high risk transplantation rejection models were set up using Fisher 344 and Lewis rats. The experimental rats were injected intraperitoneally with 0.2 ml SEB at different concentrations before keratoplasty. The rejection indexes of the allograft were recorded and the lymphocyte infiltration in the allograft and the percentage of the lymphocyte subpopulation in the lymphatic organs were also examined. Lymphocyte proliferation ability and the concentration of IL-2 and IL-10 in the serum were also evaluated.

Results: Compared with the control group, SEB prolonged the survival time of the allograft significantly from 7 to 12 days. It could also reduce CD4+ and CD8+ lymphocyte infiltration in the allograft and minimise the percentage of CD4+ and CD8+ lymphocytes in the lymphatic organs. The lymphocyte proliferation ability was also weakened. However, the percentage of CD4+ NK T lymphocytes in the lymphatic organs was raised. The serum concentration of IL-10 was higher but IL-2 was lower in the SEB treated groups.

Conclusions: SEB prolonged the survival time of the allograft in high risk rat corneal allo-transplantation, which may be caused by T cell deletion and acquisition of non-specific tolerance.


Abbreviations: ACAID, anterior chamber associated immune deviation; BSA, bovine serum albumin; ConA, concanavalin-A; ELISA, enzyme linked immunosorbent assay; HRP, horseradish peroxidase; MTT, methyl thiazolyl tetrazolium; NK, natural killer; OD, optical density; SEB, staphylococcal enterotoxin B

Keywords: corneal transplantation; immune rejection; rat; superantigen; tolerance







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.